この記事の翻訳を準備しています。それまでの間、英語の原文を表示します。
ビジネス · 1996/10/241 分で読めます
Guidant Corp.; Premarket Approval of SELUTERegister Steroid Eluting Endocardial Lead Models 4185 and 4285
ローカル自動翻訳 · 情報源の原言語
概要
The Food and Drug Administration (FDA) is announcing its approval of the application by Guidant Corp., St. Paul, MN, for premarket approval, under the Federal Food, Drug, and Cosmetic Act (the act), of SELUTE Steroid Eluting Endocardial Lead Models 4185 and 4285. FDA's Center for Devices and Radiological Health (CDRH) notified the applicant, by letter of May 8, 1996, of the approval of the application.
情報源の原言語: Federal Register — Food and Drug Administration原文の発表を開く →